Search Results - "Gorelov, Andrei I."

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial by Wood, Christopher, MD, Srivastava, Pramod, MD, Bukowski, Ronald, MD, Lacombe, Louis, MD, Gorelov, Andrei I, MD, Gorelov, Sergei, MD, Mulders, Peter, MD, Zielinski, Henryk, MD, Hoos, Axel, MD, Teofilovici, Florentina, MD, Isakov, Leah, MS, Flanigan, Robert, MD, Figlin, Robert, MD, Gupta, Renu, MD, Escudier, Bernard, MD

“…Summary Background Treatment of localised renal cell carcinoma consists of partial or radical nephrectomy. A substantial proportion of patients are at risk for…”
Get full text

Therapeutic potential of mesenchymal stem cells and stem cell-derived extracellular vesicles in tuberculosis of various localizations: A review by Shumko, Veronika V., Gorelov, Andrei I., Remezova, Anna N., Ivanova, Yanina G., Muraviov, Alexandr N., Yudintceva, Natalia M., Vinogradova, Tatiana I., Gorelova, Anna A.

“…Experimental and clinical studies using cell therapy are very popular. Mesenchymal stem cells (MSCs) and stem cell-derived extracellular vesicles (EV) are used…”
Get full text

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma : a multicentre, open-label, randomised phase III trial. Commentary by YANG, James C, WOOD, Christopher, TEOFILOVICI, Florentina, ISAKOV, Leah, FLANIGAN, Robert, FIGLIN, Robert, GUPTA, Renu, ESCUDIER, Bernard, SRIVASTAVA, Pramod, BUKOWSKI, Ronald, LACOMBE, Louis, GORELOV, Andrei I, GORELOV, Sergei, MULDERS, Peter, ZIELINSKI, Henryk, HOOS, Axel

Get full text